Primary information |
---|
sequence ID | Seq_4354 |
Peptide sequence | KREEAPSLRPAPPPISGGGYR |
CancerPDF_ID | CancerPDF_ID843, CancerPDF_ID2791, CancerPDF_ID9489, CancerPDF_ID10517, |
PMID | 19795908,21136997,26379225,21805675 |
Protein Name | Fibrinogen beta chain,Fibrinogen beta chain,Fibrinogen beta chain,Fibrinogen beta chain |
UniprotKB Entry Name | FIBB_HUMAN,FIBB_HUMAN,FIBB_HUMAN,FIBB_HUMAN |
Fluid | Plasma,Plasma,Plasma,Urine |
M/Z | 745.73,2234.192,2235.21,2235.2016 |
Charge | 3,1,NA,NA |
Mass (in Da) | NA,NA,NA,NA |
fdr | NA,NA,NA,NA |
Profiling Technique | LC-MS,LC-MS,MALDI-TOF,MALDI-TOF |
Peptide Identification technique | MALDI-TOF/TOF,LC-MS-MS/MS,MALDI-TOF/TOF,MALDI-TOF-MS |
Quantification Technique | LC-MRM (multiple reaction monitoring),LC-ESI-MS,NA,NA |
Labelled/Label Free | Labelled,Label Free,Label Free,Label Free |
FDR | less than 7%,NA,NA,1 |
CancerPDF_ID | CancerPDF_ID843, CancerPDF_ID2791, CancerPDF_ID9489, CancerPDF_ID10517, |
p-Value | NA,NA,NA,NA |
Software | FlexAnalysis 3.0 and Biotools 3.0 software,MASCOT(v. 2.2.01),MASCOT (v 2.3),NA |
Length | 21,21,21,21 |
Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Normal,Colorectal cancer,Muscle-invasive bladder cancer |
Database | NCBI refseq Protein Database,SwissProt Database,UniprotKB,SwissProt Database |
Modification | NA,NA,NA,NA |
Number of Patients | "42 normal, 26 patients",27 healthy individuals,"94 patients with CRC, 23 with liver metastasis from CRC (histologically defined) and 34 subjects, which underwent colonoscopy and resulted negative",751 bladder cancer and 127 control |
Regulation | NA,NA,"Similar median ion intensity between controls and liver metastasis, and higher median ion intensity for adenoma and CRC groups.",Differentially expressed between cancer vs normal samples |
Validation | NA,Leave One out Cross validation,NA,Mann-Whitney tests and areas under receiver-operator characteristic |
Sensitivity | NA,NA,NA,NA |
Specificity | NA,NA,NA,NA |
Accuracy | NA,NA,NA,NA |
Peptide Atlas | PeptideAtlas |
IEDB | |